Scientists track tiny doses of experimental drug to map tumors
NCT ID NCT01269593
Summary
This early study aims to understand how a new drug called PUH71 moves through the body and gathers in tumors when given in very small amounts. Researchers will use PET scans to track the drug in patients with various cancers, including lymphoma, myeloma, and solid tumors. The results will help plan future studies to test if PUH71 could be used for cancer treatment or as a tool to help detect tumors with imaging machines.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.